View
Semantic Search: Peptides That Require Different Reconstitution Solutions — Drop Your Experience Below
Peptides That Require Different Reconstitution Solutions — Drop Your Experience Below
Score 0.877
· Account tjphuhs@gmail.com
· 4/6/2026, 3:29:37 PM
Peptides That Require Different Reconstitution Solutions — Drop Your Experience Below from derekpruski@substack.com on 2026-04-06T19:29:37.000Z View this post on the web at https://derekpruski.substack.com/p/peptides-that-require-different-reconstitution Some peptides need a little extra attention when it comes to reconstitution — wrong solvent, wrong temp, or wrong technique and you’re either looking at a cloudy vial or a peptide that won’t dissolve at all. Here’s what’s worked from personal re
Why You Shouldn't Blend Your Own Peptides
Score 0.744
· Account tjphuhs@gmail.com
· 3/31/2026, 10:15:58 AM
Why You Shouldn't Blend Your Own Peptides from derekpruski@substack.com on 2026-03-31T14:15:58.000Z if the combined pH pushes GHK-Cu outside its stable window, you’re no longer working with an intact peptide. Bacteriostatic water isn’t a neutral variable Most people assume bac water is just water. It’s not — it contains 0.9% benzyl alcohol as a preservative, and its pH can shift differently depending on which peptide and environment it’s introduced into. A study looking at peptide crafter bacter
Why You Shouldn't Blend Your Own Peptides
Score 0.724
· Account tjphuhs@gmail.com
· 3/31/2026, 10:15:58 AM
Why You Shouldn't Blend Your Own Peptides from derekpruski@substack.com on 2026-03-31T14:15:58.000Z View this post on the web at https://derekpruski.substack.com/p/why-you-shouldnt-blend-your-own-peptides Quick transparency note before we get into this: I’m actively working on putting together a more formal study on this topic. What I’m sharing here is based on current science and reasoning — the goal is to eventually confirm whether this is myth or reality with real data. But based on what we k
Mold Toxicity & Peptides: A Comprehensive Walkthrough
Score 0.717
· Account tjphuhs@gmail.com
· 4/28/2026, 7:52:08 PM
Mold Toxicity & Peptides: A Comprehensive Walkthrough from derekpruski@substack.com on 2026-04-28T23:52:08.000Z works, but it’s downstream — you’re catching toxins after they’re already loose, hoping to clear them faster than they’re being released. It can take 5 to 8 years on this approach, and a lot of people stall out. The newer framework looks upstream — fix the immune system and mitochondria first, then detox. The logic: If your immune system is broken, it can’t recognize or clear what’s co
Fwd: What Do You Do When Your First Vial Is Running Low?
Score 0.701
· Account tjphuhs@gmail.com
· 3/15/2026, 2:46:14 PM
Fwd: What Do You Do When Your First Vial Is Running Low? from tjphuhs@gmail.com on 2026-03-15T18:46:14.000Z > > 1. > Draw whatever is left in the original vial into your research syringe > 2. > Research with that partial amount first > 3. > Dispose of that vial and all used supplies > 4. > Grab fresh supplies — new syringe, new needle, everything > 5. > Reconstitute or draw from your new vial fresh > > That’s it. Clean break between the two. > Why Not Just Combine Them? > This is where it gets a
Fwd: What Do You Do When Your First Vial Is Running Low?
Score 0.701
· Account oc.tjphuhs@gmail.com
· 3/15/2026, 2:46:14 PM
Fwd: What Do You Do When Your First Vial Is Running Low? from tjphuhs@gmail.com on 2026-03-15T18:46:14.000Z > > 1. > Draw whatever is left in the original vial into your research syringe > 2. > Research with that partial amount first > 3. > Dispose of that vial and all used supplies > 4. > Grab fresh supplies — new syringe, new needle, everything > 5. > Reconstitute or draw from your new vial fresh > > That’s it. Clean break between the two. > Why Not Just Combine Them? > This is where it gets a
Fwd: What Do You Do When Your First Vial Is Running Low?
Score 0.699
· Account tjphuhs@gmail.com
· 3/15/2026, 2:46:14 PM
Fwd: What Do You Do When Your First Vial Is Running Low? from tjphuhs@gmail.com on 2026-03-15T18:46:14.000Z peptide is no longer properly dissolved and you can’t accurately dose it. > > None of those outcomes are what you want in a research setting where precision and consistency matter. > The Simple Rule > Treat each vial as its own sterile environment. Use it, finish it or toss what’s left, and start fresh. A few extra minutes of setup is worth protecting the integrity of your research compoun
Fwd: What Do You Do When Your First Vial Is Running Low?
Score 0.699
· Account oc.tjphuhs@gmail.com
· 3/15/2026, 2:46:14 PM
Fwd: What Do You Do When Your First Vial Is Running Low? from tjphuhs@gmail.com on 2026-03-15T18:46:14.000Z peptide is no longer properly dissolved and you can’t accurately dose it. > > None of those outcomes are what you want in a research setting where precision and consistency matter. > The Simple Rule > Treat each vial as its own sterile environment. Use it, finish it or toss what’s left, and start fresh. A few extra minutes of setup is worth protecting the integrity of your research compoun
What Do You Do When Your First Vial Is Running Low?
Score 0.698
· Account tjphuhs@gmail.com
· 3/15/2026, 10:50:16 AM
What Do You Do When Your First Vial Is Running Low? from derekpruski@substack.com on 2026-03-15T14:50:16.000Z cloudiness is a sign the peptide structure may be compromised. Gelling. Some lyophilized peptides are sensitive to environmental changes. Combining two solutions under different conditions can cause them to gel up or form aggregates — meaning the peptide is no longer properly dissolved and you can’t accurately dose it. None of those outcomes are what you want in a research setting where
Mold Toxicity & Peptides: A Comprehensive Walkthrough
Score 0.690
· Account tjphuhs@gmail.com
· 4/28/2026, 7:52:08 PM
Mold Toxicity & Peptides: A Comprehensive Walkthrough from derekpruski@substack.com on 2026-04-28T23:52:08.000Z can work. The “arginine salt” version of certain peptides looks similar on a label but doesn’t survive — it’s marketed as “stable” but functionally less effective. Section 5: The Layered Research Framework This is the sequencing that’s emerging from clinical observation. Each layer prepares the system for the next. Skipping ahead causes problems — running offensive peptides before defe
Fwd: The Ultimate Peptide Travel Stack
Score 0.684
· Account tjphuhs@gmail.com
· 3/18/2026, 10:50:17 PM
Fwd: The Ultimate Peptide Travel Stack from tjphuhs@gmail.com on 2026-03-19T02:50:17.000Z stack is built around actually making it that way — not just surviving the trip, but coming back feeling like you did something genuinely good for your body in the process. > Obviously you can run your normal research protocols on top of this. These are just the ones I’d specifically target for travel. If there are any you’d add to this list or any you’d swap out, drop them in the comments. > For educationa
Why Peptide Cycles Look Like a Slope, Not a Light Switch
Score 0.684
· Account tjphuhs@gmail.com
· 3/29/2026, 9:14:23 PM
Why Peptide Cycles Look Like a Slope, Not a Light Switch from derekpruski@substack.com on 2026-03-30T01:14:23.000Z a compound repeatedly — especially at higher doses — they adapt. They downregulate. They become less responsive to the same signal. This is the body protecting itself from overstimulation. Here’s the important part: the peptide leaving the system does not automatically reset receptor sensitivity. If a researcher ran a high dose protocol for an extended period, the receptors that wer
Does Shaking Damage Reconstituted Peptides?
Score 0.683
· Account tjphuhs@gmail.com
· 2/9/2026, 1:51:34 PM
Does Shaking Damage Reconstituted Peptides? from support@peptidecrafters.com on 2026-02-09T18:51:34.000Z Hello, You have received a newsletter from Peptide Crafters. However, your email software can't display HTML emails. You can view the newsletter by clicking here: https://yygbxo.clicks.mlsend.com/ty/c/eyJ2Ijoie1wiYVwiOjk2MDczNSxcImxcIjoxNzg5NTMxMzY1Njg3OTY3NTIsXCJyXCI6MTc4OTUzMTU5Mjg3MjQzODAxfSIsInMiOiJlMGExZjA2OGNhN2ZjZWU2In0 You're receiving this newsletter because you have shown interest i
Fwd: Synergy Over Maximalism: The Part of Stacking Nobody Talks About
Score 0.679
· Account tjphuhs@gmail.com
· 3/25/2026, 12:17:01 PM
Fwd: Synergy Over Maximalism: The Part of Stacking Nobody Talks About from tjphuhs@gmail.com on 2026-03-25T16:17:01.000Z the second and gauge the additive effect before making any adjustments. > Mitochondrial peptides follow the same logic. If SS-31, MOTS-c, NAD+, and SLU are all pushing mitochondrial output upward simultaneously in the RS, running each at its individual maximum protocol is redundant at best and counterproductive at worst. You lose signal, you lose control, and you’re not using
Fwd: Synergy Over Maximalism: The Part of Stacking Nobody Talks About
Score 0.679
· Account oc.tjphuhs@gmail.com
· 3/25/2026, 12:17:01 PM
Fwd: Synergy Over Maximalism: The Part of Stacking Nobody Talks About from tjphuhs@gmail.com on 2026-03-25T16:17:01.000Z the second and gauge the additive effect before making any adjustments. > Mitochondrial peptides follow the same logic. If SS-31, MOTS-c, NAD+, and SLU are all pushing mitochondrial output upward simultaneously in the RS, running each at its individual maximum protocol is redundant at best and counterproductive at worst. You lose signal, you lose control, and you’re not using
Mold Toxicity & Peptides: A Comprehensive Walkthrough
Score 0.677
· Account tjphuhs@gmail.com
· 4/28/2026, 7:52:08 PM
Mold Toxicity & Peptides: A Comprehensive Walkthrough from derekpruski@substack.com on 2026-04-28T23:52:08.000Z already running. It’s an offensive weapon. You don’t deploy offense before the defense is built. Research dosing in the literature varies considerably. The principle that holds across the published work: start at a fraction of the target dose and titrate up. If an RS reacts to half a Peptide-S capsule, they’re going to react to LL-37 — period. Some research protocols start at 10% of th
Why Peptide Cycles Look Like a Slope, Not a Light Switch
Score 0.674
· Account tjphuhs@gmail.com
· 3/29/2026, 9:14:23 PM
Why Peptide Cycles Look Like a Slope, Not a Light Switch from derekpruski@substack.com on 2026-03-30T01:14:23.000Z View this post on the web at https://derekpruski.substack.com/p/why-peptide-cycles-look-like-a-slope Most researchers picture peptide effects like flipping a switch. You dose, it works. You stop, it’s done. That mental model is going to set you up for frustration. The reality is much closer to a slow incline and a slow decline — a gradual ramp up, a peak somewhere in the middle, and
Mold Toxicity & Peptides: A Comprehensive Walkthrough
Score 0.671
· Account tjphuhs@gmail.com
· 4/28/2026, 7:52:08 PM
Mold Toxicity & Peptides: A Comprehensive Walkthrough from derekpruski@substack.com on 2026-04-28T23:52:08.000Z pharmaceutical compounds like Larazotide and Rebamipide, compounding pharmacy sourcing is the standard route. On expectations. This framework typically cuts recovery time significantly compared to binder-only approaches — the kind of timeline where what used to take 5 years takes 1 to 2, and milder cases sometimes resolve in months. But CIRS is genuinely complex, and individual respons
Mold Toxicity & Peptides: A Comprehensive Walkthrough
Score 0.669
· Account tjphuhs@gmail.com
· 4/28/2026, 7:52:08 PM
Mold Toxicity & Peptides: A Comprehensive Walkthrough from derekpruski@substack.com on 2026-04-28T23:52:08.000Z Works This is where binders, sauna, glutathione support, and all the standard detox protocols suddenly start producing results in weeks instead of years. The immune system can recognize what to clear, the mitochondria have the energy to push toxins out of cells, and the barriers hold so you don’t re-absorb what you just excreted. This is also where addressing chronic infections fits —
Peptidology Just Upgraded Their Testing Standard and Their Discount
Score 0.669
· Account tjphuhs@gmail.com
· 4/8/2026, 12:15:30 PM
Peptidology Just Upgraded Their Testing Standard and Their Discount from derekpruski@substack.com on 2026-04-08T16:15:30.000Z is a test a lot of vendors skip entirely. ICP-MS Heavy Metals ICP-MS (Inductively Coupled Plasma Mass Spectrometry) screens for toxic heavy metals: lead, arsenic, cadmium, mercury, and chromium. These can enter a product through the raw materials used in synthesis or through manufacturing equipment. You won’t taste or see them, and they won’t show up on a purity test — wh
Fwd: A Molecular Stapler Could Make GLP-1 Drugs Last Longer. Scientists Borrowed It From Bacteria.
Score 0.667
· Account tjphuhs@gmail.com
· 5/3/2026, 2:45:39 PM
Fwd: A Molecular Stapler Could Make GLP-1 Drugs Last Longer. Scientists Borrowed It From Bacteria. from tjphuhs@gmail.com on 2026-05-03T18:45:39.000Z stapler that loops the tail back and snaps it into a closed ring. An exoprotease trying to attack from that end suddenly has nowhere to grab. The key holds its shape longer. It stays in the lock. > The scientific community knew PapB existed, but it was considered too finicky to be broadly useful as a drug development tool. The enzyme was believed t
Fwd: A Molecular Stapler Could Make GLP-1 Drugs Last Longer. Scientists Borrowed It From Bacteria.
Score 0.667
· Account oc.tjphuhs@gmail.com
· 5/3/2026, 2:45:39 PM
Fwd: A Molecular Stapler Could Make GLP-1 Drugs Last Longer. Scientists Borrowed It From Bacteria. from tjphuhs@gmail.com on 2026-05-03T18:45:39.000Z stapler that loops the tail back and snaps it into a closed ring. An exoprotease trying to attack from that end suddenly has nowhere to grab. The key holds its shape longer. It stays in the lock. > The scientific community knew PapB existed, but it was considered too finicky to be broadly useful as a drug development tool. The enzyme was believed t
Research Radar Ep. 1: Payments, Peptides & Proper Testing
Score 0.667
· Account tjphuhs@gmail.com
· 4/3/2026, 10:19:48 AM
Research Radar Ep. 1: Payments, Peptides & Proper Testing from derekpruski@substack.com on 2026-04-03T14:19:48.000Z is a meaningful development. Holding alternative delivery formats to the same documentation standards as injectables raises the bar across the board and gives researchers more confidence when evaluating non-injectable options. Listener Q&A: RFK and the category 1 vs category 2 peptide reclassification Rick walked us through the regulatory background on RFK’s proposed reclassificati
Fwd: NAD+ / MOTS-c / 5-Amino-1MQ: Breaking Down The Blend
Score 0.665
· Account oc.tjphuhs@gmail.com
· 3/27/2026, 4:33:04 PM
Fwd: NAD+ / MOTS-c / 5-Amino-1MQ: Breaking Down The Blend from tjphuhs@gmail.com on 2026-03-27T20:33:04.000Z what mitochondria need to produce ATP and activates repair proteins that depend on it. > MOTS-c is the capacity builder — it signals the body to create more mitochondria and become more metabolically efficient, amplifying what NAD+ can do. > 5-Amino-1MQ is the preservation mechanism — it blocks the enzyme that degrades NAD+ precursors, extending the effectiveness of the NAD+ being supplie
Fwd: NAD+ / MOTS-c / 5-Amino-1MQ: Breaking Down The Blend
Score 0.665
· Account tjphuhs@gmail.com
· 3/27/2026, 4:33:04 PM
Fwd: NAD+ / MOTS-c / 5-Amino-1MQ: Breaking Down The Blend from tjphuhs@gmail.com on 2026-03-27T20:33:04.000Z what mitochondria need to produce ATP and activates repair proteins that depend on it. > MOTS-c is the capacity builder — it signals the body to create more mitochondria and become more metabolically efficient, amplifying what NAD+ can do. > 5-Amino-1MQ is the preservation mechanism — it blocks the enzyme that degrades NAD+ precursors, extending the effectiveness of the NAD+ being supplie